Environmental And Genetic Influence On Cognition In Als-Ftd Spectrum Disease

Loading...
Thumbnail Image
Degree type
Doctor of Philosophy (PhD)
Graduate group
Neuroscience
Discipline
Subject
Amyotrophic Lateral Sclerosis
Frontotemporal Degeneration
Bioinformatics
Neuroscience and Neurobiology
Funder
Grant number
License
Copyright date
2021-08-31T20:20:00-07:00
Distributor
Related resources
Author
Placek, Katerina
Contributor
Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) are earlier-onset, fatal neurodegenerative diseases that progressively rob affected individuals of their cognitive faculties and their ability to move freely, produce coherent speech, and be their former selves. Diagnosis precedes death by <10 >years, and current interventions are limited to palliative or disease-slowing therapies. Recent seminal research has revealed that ALS and FTD are phenotypic extremes on a continuous spectrum with shared symptoms, pathobiology, and genetics. Despite increased knowledge of ALS-FTD spectrum disease, prognostication and therapeutic development are limited by immense phenotypic heterogeneity. One source of this heterogeneity is cognition: individuals across the ALS-FTD disease spectrum suffer varying degrees of decline in cognition due to neurodegeneration in the frontal and temporal lobes. Cognition is inextricably linked to functional ability and survival, and is thus a promising candidate for a prognostic marker and therapeutic target. With this in mind, the goal of my thesis work is to elucidate factors that influence the heterogeneity of cognitive impairment and corresponding frontotemporal neurodegeneration in ALS-FTD spectrum disease. I pursue this goal by studying clinical, demographic, genetic, anatomic, and biologic data from deeply-phenotyped patient populations and applying robust statistical approaches including multimodal, nonparametric, and machine learning analyses. My work demonstrates strong environmental and genetic contribution to cognition and frontotemporal disease anatomy in ALS-FTD spectrum disease, and suggests their importance to advancements in clinical care and therapeutic development.

Advisor
David A. Wolk
Date of degree
2020-01-01
Date Range for Data Collection (Start Date)
Date Range for Data Collection (End Date)
Digital Object Identifier
Series name and number
Volume number
Issue number
Publisher
Publisher DOI
Journal Issue
Comments
Recommended citation